Beijing Chunlizhengda Medical Instruments Co., Ltd.
SSE:688236.SS
16.77 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 805.857 | 1,208.524 | 1,201.604 | 1,108.14 | 937.686 | 855.327 | 497.927 | 300.317 | 207.926 | 177.369 | 134.534 | 110.546 | 98.095 |
| Cost of Revenue
| 268.953 | 353.343 | 288.078 | 253.599 | 256.931 | 261.867 | 180.003 | 84.063 | 48.261 | 55.28 | 34.957 | 30.471 | 27.536 |
| Gross Profit
| 536.904 | 855.181 | 913.527 | 854.54 | 680.756 | 593.459 | 317.924 | 216.254 | 159.665 | 122.089 | 99.578 | 80.075 | 70.559 |
| Gross Profit Ratio
| 0.666 | 0.708 | 0.76 | 0.771 | 0.726 | 0.694 | 0.638 | 0.72 | 0.768 | 0.688 | 0.74 | 0.724 | 0.719 |
| Reseach & Development Expenses
| 119.889 | 157.446 | 162.341 | 104.843 | 72.603 | 57.747 | 35.455 | 21.216 | 14.282 | 13.318 | 8.002 | 4.808 | 4.873 |
| General & Administrative Expenses
| 0 | 9.7 | 10.952 | 10.682 | 14.202 | 7.382 | 6.207 | 6.888 | 6.092 | 24.338 | 18.554 | 13.585 | 14.863 |
| Selling & Marketing Expenses
| 0 | 383.14 | 288.885 | 342.055 | 241.011 | 225.79 | 143.914 | 88.948 | 52.228 | 23.624 | 12.934 | 8.324 | 16.137 |
| SG&A
| 280.385 | 432.026 | 299.837 | 352.736 | 255.213 | 233.172 | 150.121 | 95.836 | 58.32 | 47.961 | 31.488 | 21.909 | 33.197 |
| Other Expenses
| -18.745 | -40.266 | 119.013 | 11.726 | 18.103 | 18.757 | -0.15 | -0.186 | -0.587 | 22.119 | 0.664 | 0.586 | 0 |
| Operating Expenses
| 406.189 | 549.205 | 581.19 | 469.305 | 345.92 | 309.676 | 201.145 | 135.243 | 86.371 | 83.398 | 56.305 | 41.898 | 33.521 |
| Operating Income
| 130.715 | 305.975 | 328.909 | 367.592 | 330.096 | 298.577 | 116.779 | 81.011 | 73.294 | 38.691 | 43.273 | 38.177 | 36.148 |
| Operating Income Ratio
| 0.162 | 0.253 | 0.274 | 0.332 | 0.352 | 0.349 | 0.235 | 0.27 | 0.353 | 0.218 | 0.322 | 0.345 | 0.369 |
| Total Other Income Expenses Net
| 0.884 | -0.07 | 7.971 | -0.213 | -0.249 | -0.539 | 9.697 | -0.186 | 2.931 | -0.002 | -0.36 | -0.061 | 1.055 |
| Income Before Tax
| 131.599 | 305.906 | 336.88 | 367.379 | 329.847 | 273.001 | 119.449 | 78.796 | 73.744 | 43.494 | 42.913 | 38.116 | 37.203 |
| Income Before Tax Ratio
| 0.163 | 0.253 | 0.28 | 0.332 | 0.352 | 0.319 | 0.24 | 0.262 | 0.355 | 0.245 | 0.319 | 0.345 | 0.379 |
| Income Tax Expense
| 6.938 | 28.088 | 29.161 | 45.018 | 46.473 | 36.239 | 13.803 | 10.512 | 10.303 | 5.629 | 5.882 | 5.451 | 5.263 |
| Net Income
| 124.988 | 277.824 | 307.719 | 322.361 | 283.373 | 236.761 | 105.646 | 68.284 | 63.441 | 37.866 | 37.031 | 32.665 | 31.94 |
| Net Income Ratio
| 0.155 | 0.23 | 0.256 | 0.291 | 0.302 | 0.277 | 0.212 | 0.227 | 0.305 | 0.213 | 0.275 | 0.295 | 0.326 |
| EPS
| 0.33 | 0.72 | 0.8 | 0.84 | 0.82 | 0.68 | 0.31 | 0.2 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| EPS Diluted
| 0.33 | 0.72 | 0.8 | 0.84 | 0.82 | 0.68 | 0.31 | 0.2 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| EBITDA
| 169.321 | 340.926 | 367.292 | 386.161 | 345.155 | 285.14 | 124.196 | 87.519 | 79.811 | 48.447 | 48.023 | 42.112 | 40.338 |
| EBITDA Ratio
| 0.21 | 0.282 | 0.306 | 0.348 | 0.368 | 0.333 | 0.249 | 0.291 | 0.384 | 0.273 | 0.357 | 0.381 | 0.411 |